FDA approves new multiple sclerosis treatment: Tecfidera
03/27/2013 03:30 PM EDT
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).
http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTMwMzI3LjE3MTQzODExJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDEzMDMyNy4xNzE0MzgxMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE2Nzg0OTUwJmVtYWlsaWQ9amltdGFrZWRhQGdtYWlsLmNvbSZ1c2VyaWQ9amltdGFrZWRhQGdtYWlsLmNvbSZmbD0mZXh0cmE9TXVsdGl2YXJpYXRlSWQ9JiYm&&&100&&&http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htm?source=govdelivery